Intensity Therapeutics In... (INTS)

2.35

0.09 (3.98%)

At close: Feb 28, 2025, 3:59 PM

2.34

-0.43%

After-hours: Feb 28, 2025, 04:00 PM EST

Intensity Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-10.54M	-7.58M	-7.9M	-6.03M	-5.38M
Depreciation & Amortization	n/a	179.04K	n/a	n/a	n/a
Stock-Based Compensation	1.4M	1.17M	719.82K	555.49K	561.38K
Other Working Capital	-2.26M	326.02K	227K	159.22K	104.36K
Other Non-Cash Items	2.57M	179.04K	172.11K	116.83K	95.21K
Deferred Income Tax	n/a	-179.04K	n/a	n/a	n/a
Change in Working Capital	-633K	756.69K	176.8K	-12.03K	306.91K
Operating Cash Flow	-7.21M	-5.48M	-6.83M	-5.37M	-4.42M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-15.05M	n/a	n/a	-10.9M	-7.07M
Sales Maturities Of Investments	9.03M	n/a	n/a	15.46M	8.77M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-6.02M	n/a	n/a	4.56M	1.7M
Debt Repayment	230K	2.25M	2M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.18M	n/a	50K	6.29M	3.86M
Financial Cash Flow	20.47M	2.25M	2.05M	6.29M	3.86M
Net Cash Flow	7.24M	-3.23M	-4.78M	5.49M	1.14M
Free Cash Flow	-7.21M	-5.48M	-6.83M	-5.37M	-4.42M